PPAR-γ agonist pioglitazone reduces microglial proliferation and NF-κB activation in the substantia nigra in the 6-hydroxydopamine model of Parkinson’s disease

Published 2018 View Full Article

Authors

Keywords

Parkinson’s disease, Pioglitazone, PPAR-γ, NF-κB, Neuroinflammation

Journal

Pharmacological Reports

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2018-12-01

DOI

10.1016/j.pharep.2018.11.005

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.